Therefore, we considered whether the activation of Wnt and PI3K signaling is a more universal process in ICC formation and sought to address whether these pathways are recurrently activated in ICC lacking RAS mutations, particularly given the majority of ICC patient cancers (79.07%) do not carry a mutation in either Kras or Nras (Supplementary Table S4). This evidence concerns the gene PIK3CA and cancer.